The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Ukip have launched their General Election manifesto in a return to political campaigning following the Manchester suicide bombing.
Manchester United want Renato Sanches and Everton slap £50m price tag on Ross Barkley with Spurs interested.
Shoppers who don't bring their own bag will need to buy a bag for life costing 8p or 10p.